THE RISKS OF IMPLEMENTING GENOMIC RESEARCH PROGRAMMES IN THE RUSSIAN FEDERATION

In order to implement The strategy of scientific and technological development of the Russian Federation, the state program of genomic research and the complex scientific and technological program “Postgenomic technologies: from genetic editing to synthetic biology” are planned to be implemented in the country. Noting the obvious prospects and expediency of the development of post-genome editing technologies and high-tech industries based on them, the authors of the article highlight the barriers and risks of the full life cycle projects: the lack of sufficient number of personnel, the low level of competitiveness of domestic scientific and technological reserves, the lack of modern instrumentation, the lack of industrial partners, as well as the problems of normative and legal regulation of genetic engineering activities in the Russian Federation. Made in the framework of the study the analysis of global competitive landscape in the technology of genome editing showed that by 2018, several multinational companies have established a strong portfolio of patent documents as a tool for the conquest of leading positions in the markets generated by the post-genomic technologies.

1. Verbatim report on the meeting of the Council for Science and Education on February 8, 2018 (2018) / The official website of the President of Russia. http://www. kremlin.ru/events/president/news/56827.

2. The Ministry of Education and Science proposed a program for the creation of artificial organisms (2018) / RIA Science, 30.01.2018. https://ria.ru/science/20180130/1513621035.html.

3. Rebrikov D.V. (2016) Editing of the human genome // Bulletin of RNIMU im. N.I. Pirogova. № 3. P. 4–15.

4. Petukhov S., Glukhovskaya Yu. (2017) We went against the genes. New technologies for editing the human genome have opened the possibility of adjusting the “life instructions” / RBC, St. Petersburg International Economic Forum. Issue 1. http://www. rbcplus.ru/news/592f68fa7a8aa95ad75b6f08.

5. The “road map” of “Helsnet” of the National Technological Initiative was approved by the decision of the Presidium of the Council under the President of the Russian Federation on Economic Modernization and Innovative Development of Russia dated 20 December 2016, Minutes № 6 (2016) / NTI. http://www. nti2035.ru/markets/healthnet.

6. Kuluev B.R., Geraschenkov G.А. et al. (2017) Сrispr/ cas editing of plant genomes // Biomica. V. 9. № 3. P. 155–182.

7. Genomic editing (2017) Transcript of the strategic session in the framework of the VI International Forum of Technological Development “Technoprom 2017” / Technoprom. http://forumtechnoprom.com/page/376.

8. Petrov А.N., Kurakova N.G., Son I.М. (2017) Approaches to the design and examination of complex scientific and technological programs and projects // Innovations. № 9 (227). P. 19–27.

9. Pokrovsky A.G. (2015) Brainstorming. Personalized medicine – transcript of speech / Technoprom. http://forumtechnoprom.com/data/files/1.

10. Gorina M., Kotalevskaya Yu. (2013) The patient’s genetics should be sent to the local doctor or a specialist, and this does not always happen when / Bolshoi gorod. 08.02.2013. http://bg.ru/ health/julija_kotalevskaja_k_genetiku_patsienta_ dolzhen_n 17054.

11. Lyudmirsky D. (2018) In the “Skolkovo” create the decoder of the genome. Russian startup develops an inexpensive DNA sequencer for mass use / Izvestiya. Science, 12.03.2018. https://iz.ru/716596/dmitriiliudmirskii/v-skolkovo-sozdaiut-deshifrator-genoma.

12. Romanovsky G.B. (2017) Legal Regulation of Genetic Research in Russia and Abroad / Otrasli prava, 18.02.2017. http://отрасли-права.рф/article/22490.

13. Public analytical report on the scientific and technological direction “Biomedicine” (2015) / Ministry of Health of Russia. https://reestr.extech.ru/docs/analytic/reports/medicine.pdf.

14. Zabello Ja. (2010) Lessons of the first: How BASF and DuPont achieve success // SIBUR today. http://www. up-pro.ru/library/strategy/management/basf-dupont-yroki-pervyh.html.